US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 26.100
  • -0.670-2.50%
Close Apr 18 16:00 ET
  • 25.740
  • -0.360-1.38%
Post 16:57 ET
1.21BMarket Cap29.33P/E (TTM)

Pacira BioSciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
-29.25%42.65M
-1.09%29.81M
154.76%30.78M
Net income from continuing operations
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
4.17%19.88M
-34.15%6.83M
Operating gains losses
--16.93M
--0
---11K
-87.59%34K
62,503.70%16.9M
----
----
----
-88.80%274K
-81.25%27K
Depreciation and amortization
-17.41%75.57M
-39.21%18.49M
-8.74%18.43M
-8.68%19.05M
-2.15%19.6M
220.52%91.5M
132.64%30.41M
252.50%20.2M
326.06%20.86M
312.97%20.03M
Deferred tax
296.54%15.62M
160.89%6.6M
600.00%4.91M
428.74%11.44M
-25,417.24%-7.34M
-173.08%-7.95M
-420.90%-10.84M
-86.85%702K
-63.12%2.16M
-98.34%29K
Other non cash items
111.19%2.46M
121.19%854K
534.08%5.92M
10.97%-17.54M
1,525.31%13.23M
-205.97%-21.98M
-143.19%-4.03M
-82.56%933K
-2,338.64%-19.7M
-84.29%814K
Change In working capital
-178.57%-45.78M
-608.93%-15.65M
-846.02%-8.2M
-19.06%-6.21M
-93.04%-15.72M
12.00%-16.43M
-835.17%-2.21M
-105.64%-867K
61.36%-5.22M
59.93%-8.14M
-Change in receivables
-244.35%-7.16M
-74.56%-8.6M
189.73%2.12M
-688.68%-5.88M
23.18%5.19M
80.07%-2.08M
63.52%-4.93M
-112.87%-2.37M
106.33%998K
812.34%4.22M
-Change in inventory
-433.47%-8.29M
-1,165.71%-7.83M
-215.86%-4.39M
-72.45%847K
160.37%3.09M
155.65%2.49M
138.54%735K
294.81%3.79M
567.17%3.07M
-11,988.37%-5.11M
-Change in prepaid assets
-257.13%-9.64M
-24.50%-2.65M
-198.20%-2.62M
-337.88%-2.44M
54.79%-1.93M
-336.34%-2.7M
-1,006.81%-2.13M
43.98%2.67M
185.73%1.03M
-1,777.17%-4.26M
-Change in payables and accrued expense
-55.49%-21.12M
-42.48%3.05M
39.60%-3.08M
113.09%1.4M
-635.99%-22.49M
-182.37%-13.59M
-59.43%5.29M
-171.95%-5.1M
-415.97%-10.72M
84.23%-3.06M
-Change in other current liabilities
178.06%434K
133.42%394K
-265.28%-238K
-134.96%-143K
501.43%421K
-434.62%-556K
-162.32%-1.18M
113.95%144K
-44.50%409K
104.12%70K
Cash from discontinued investing activities
Operating cash flow
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
-29.25%42.65M
-1.09%29.81M
154.76%30.78M
Investing cash flow
Cash flow from continuing investing activities
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
-35.46%-47.52M
531.75%19.16M
-273.70%-208.02M
Net PPE purchase and sale
49.59%-15.16M
67.26%-1.8M
34.49%-3.39M
70.99%-3.4M
14.38%-6.57M
34.43%-30.08M
40.08%-5.49M
60.38%-5.18M
-11.22%-11.74M
41.34%-7.67M
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
156.83%92.7M
-39.02%10.17M
97.76%-948K
-65.27%10.73M
143.21%72.75M
-136.32%-163.11M
-96.66%16.68M
-92.42%-42.34M
149.89%30.9M
-306.93%-168.35M
Net other investing changes
----
----
----
----
----
-700.00%-32M
--0
--0
--0
---32M
Cash from discontinued investing activities
Investing cash flow
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
-35.46%-47.52M
531.75%19.16M
-273.70%-208.02M
Financing cash flow
Cash flow from continuing financing activities
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
-354.75%-7.78M
-2,700.83%-153.66M
-1,858.69%-181.59M
Net issuance payments of debt
57.74%-180.76M
95.26%-2.81M
-196.66%-27.81M
98.31%-2.81M
23.51%-147.33M
-217.58%-427.69M
-116.32%-59.38M
---9.38M
---166.34M
---192.61M
Proceeds from stock option exercised by employees
-82.63%4.75M
-44.14%1.14M
-98.44%25K
-74.34%3.25M
-96.98%333K
2.57%27.34M
-66.20%2.04M
-47.58%1.6M
74.97%12.68M
6.77%11.02M
Net other financing activities
-497.36%-7.02M
---106K
--0
--0
---6.91M
87.90%-1.18M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
-354.75%-7.78M
-2,700.83%-153.66M
-1,858.69%-181.59M
Net cash flow
Beginning cash position
-82.22%104.14M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
485.83%585.58M
-18.36%109.42M
15.40%122.06M
239.96%226.75M
485.83%585.58M
Current changes in cash
110.21%49.16M
1,125.15%54.18M
197.40%12.31M
148.97%51.27M
80.88%-68.59M
-199.14%-481.44M
-101.17%-5.29M
-144.71%-12.64M
-367.92%-104.69M
-978.92%-358.83M
End cash Position
47.21%153.3M
47.21%153.3M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
-82.22%104.14M
-18.36%109.42M
15.40%122.06M
239.96%226.75M
Free cash flow
21.09%139.49M
25.29%45.79M
9.53%41.04M
121.87%40.1M
-45.64%12.56M
44.27%115.2M
160.13%36.55M
-20.63%37.47M
-7.72%18.07M
2,429.54%23.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M-29.25%42.65M-1.09%29.81M154.76%30.78M
Net income from continuing operations 163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K4.17%19.88M-34.15%6.83M
Operating gains losses --16.93M--0---11K-87.59%34K62,503.70%16.9M-------------88.80%274K-81.25%27K
Depreciation and amortization -17.41%75.57M-39.21%18.49M-8.74%18.43M-8.68%19.05M-2.15%19.6M220.52%91.5M132.64%30.41M252.50%20.2M326.06%20.86M312.97%20.03M
Deferred tax 296.54%15.62M160.89%6.6M600.00%4.91M428.74%11.44M-25,417.24%-7.34M-173.08%-7.95M-420.90%-10.84M-86.85%702K-63.12%2.16M-98.34%29K
Other non cash items 111.19%2.46M121.19%854K534.08%5.92M10.97%-17.54M1,525.31%13.23M-205.97%-21.98M-143.19%-4.03M-82.56%933K-2,338.64%-19.7M-84.29%814K
Change In working capital -178.57%-45.78M-608.93%-15.65M-846.02%-8.2M-19.06%-6.21M-93.04%-15.72M12.00%-16.43M-835.17%-2.21M-105.64%-867K61.36%-5.22M59.93%-8.14M
-Change in receivables -244.35%-7.16M-74.56%-8.6M189.73%2.12M-688.68%-5.88M23.18%5.19M80.07%-2.08M63.52%-4.93M-112.87%-2.37M106.33%998K812.34%4.22M
-Change in inventory -433.47%-8.29M-1,165.71%-7.83M-215.86%-4.39M-72.45%847K160.37%3.09M155.65%2.49M138.54%735K294.81%3.79M567.17%3.07M-11,988.37%-5.11M
-Change in prepaid assets -257.13%-9.64M-24.50%-2.65M-198.20%-2.62M-337.88%-2.44M54.79%-1.93M-336.34%-2.7M-1,006.81%-2.13M43.98%2.67M185.73%1.03M-1,777.17%-4.26M
-Change in payables and accrued expense -55.49%-21.12M-42.48%3.05M39.60%-3.08M113.09%1.4M-635.99%-22.49M-182.37%-13.59M-59.43%5.29M-171.95%-5.1M-415.97%-10.72M84.23%-3.06M
-Change in other current liabilities 178.06%434K133.42%394K-265.28%-238K-134.96%-143K501.43%421K-434.62%-556K-162.32%-1.18M113.95%144K-44.50%409K104.12%70K
Cash from discontinued investing activities
Operating cash flow 6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M-29.25%42.65M-1.09%29.81M154.76%30.78M
Investing cash flow
Cash flow from continuing investing activities 134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M-35.46%-47.52M531.75%19.16M-273.70%-208.02M
Net PPE purchase and sale 49.59%-15.16M67.26%-1.8M34.49%-3.39M70.99%-3.4M14.38%-6.57M34.43%-30.08M40.08%-5.49M60.38%-5.18M-11.22%-11.74M41.34%-7.67M
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale 156.83%92.7M-39.02%10.17M97.76%-948K-65.27%10.73M143.21%72.75M-136.32%-163.11M-96.66%16.68M-92.42%-42.34M149.89%30.9M-306.93%-168.35M
Net other investing changes ---------------------700.00%-32M--0--0--0---32M
Cash from discontinued investing activities
Investing cash flow 134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M-35.46%-47.52M531.75%19.16M-273.70%-208.02M
Financing cash flow
Cash flow from continuing financing activities 54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M-354.75%-7.78M-2,700.83%-153.66M-1,858.69%-181.59M
Net issuance payments of debt 57.74%-180.76M95.26%-2.81M-196.66%-27.81M98.31%-2.81M23.51%-147.33M-217.58%-427.69M-116.32%-59.38M---9.38M---166.34M---192.61M
Proceeds from stock option exercised by employees -82.63%4.75M-44.14%1.14M-98.44%25K-74.34%3.25M-96.98%333K2.57%27.34M-66.20%2.04M-47.58%1.6M74.97%12.68M6.77%11.02M
Net other financing activities -497.36%-7.02M---106K--0--0---6.91M87.90%-1.18M----------------
Cash from discontinued financing activities
Financing cash flow 54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M-354.75%-7.78M-2,700.83%-153.66M-1,858.69%-181.59M
Net cash flow
Beginning cash position -82.22%104.14M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M485.83%585.58M-18.36%109.42M15.40%122.06M239.96%226.75M485.83%585.58M
Current changes in cash 110.21%49.16M1,125.15%54.18M197.40%12.31M148.97%51.27M80.88%-68.59M-199.14%-481.44M-101.17%-5.29M-144.71%-12.64M-367.92%-104.69M-978.92%-358.83M
End cash Position 47.21%153.3M47.21%153.3M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M-82.22%104.14M-18.36%109.42M15.40%122.06M239.96%226.75M
Free cash flow 21.09%139.49M25.29%45.79M9.53%41.04M121.87%40.1M-45.64%12.56M44.27%115.2M160.13%36.55M-20.63%37.47M-7.72%18.07M2,429.54%23.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg